For example, the silencing Nrf2 can increase the sensitivity of cisplatin-resistant ovarian cancer cell strain to cisplatin and that of lung cancer cells to doxorubicin [36, 37]. The gene discussed is NFE2L2; the disease is ovarian cancer.